Evidence map›Paper›PMID 20637815›Full record

ReviewJournal of controlled release : official journal of the Controlled Release Society2010

Fibrin glue as a drug delivery system.

Patrick P Spicer, Antonios G Mikos

Abstract readReview
In one paragraph

Review in Journal of controlled release : official journal of the Controlled Release Society, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Glutaraldehyde Cross-Linking of Salt-Induced Fibrinogen Hydrogels.ACS biomaterials science & engineering · 2024
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Patrick P SpicerDepartment of Bioengineering, Rice University, Houston, TX, USA.
Antonios G MikosDepartment of Bioengineering, Rice University, Houston, TX, USA. Electronic address: mikos@rice.edu.

Funding

Regulated Osteochondrogenesis of Human Mesenchymal Stem Cells Using Gene DeliveryR21AR056076 · NIAMS · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2008 to 2009
$360k
NIAMS NIH HHS R21 AR056076
6 · The paper itself

Abstract

Fibrin glue has been used surgically for decades for hemostasis as well as a sealant. It has also been researched as both a gel for cell delivery and a vehicle for drug delivery. The drug delivery applications for fibrin glue span tissue engineering to chemotherapy and involve several mechanisms for drug matrix interactions and control of release kinetics. Additionally, drugs or factors can be loaded in the gel via impregnation and tethering to the gel through covalent linkages or affinity-based systems. This review highlights recent research of fibrin glue as a drug delivery vehicle.

Indexed as

Drug Delivery SystemsAnimalsBone Morphogenetic Protein 2Fibrin Tissue AdhesiveGenetic VectorsGlial Cell Line-Derived Neurotrophic FactorHumansTransforming Growth Factor beta1Vascular Endothelial Growth Factor ABMP2 protein, humanBone Morphogenetic Protein 2Fibrin Tissue AdhesiveGlial Cell Line-Derived Neurotrophic FactorTransforming Growth Factor beta1Vascular Endothelial Growth Factor A

Identifiers

PMID20637815
PMCPMC3005546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.